DPP4 and type 2 diabetes mellitus: At present, the medicines to treat T2DM were sodium-dependent glucose transporters 2 inhibitors, glucagon-like peptide-1 receptor agonists, DPP-4 inhibitors, Thiazolidinediones, Sulfony ureas (2nd generation) and human insulin or analogs [5].